278 patents
Page 5 of 14
Utility
Reduction In Acetate Production by Yeast Over-expressing MIG3
5 Jan 23
Described are compositions and methods relating to modified yeast that over-express MIG transcriptional regulator polypeptides.
MIN QI, QUINN QUN ZHU, JAMIE YEHONG WANG
Filed: 24 Nov 20
Utility
Stable microcapsule compositions
3 Jan 23
Disclosed are stable microcapsule compositions each containing a microcapsule dispersed in an aqueous phase and a stabilizing agent.
Yabin Lei, Li Xu
Filed: 3 Jul 17
Utility
Methods and Compositions for Remediating Cyanuric Acid In Aqueous Liquids
29 Dec 22
The present disclosure is generally related to the fields of biology, inorganic chemistry, organic chemistry, molecular biology, enzymology, chlorinated water treatment processes and the like.
Kelly Gardner Aukema, Rajdeep S. Dhaliwal, Feng Guo, Meng Hong Heng, Katherine Hoffman, Jacob Andrew Latone, Lawrence Philip Wackett, Gregory M. Whited
Filed: 14 Oct 20
Utility
Consumer Products with Improved Aesthetics
29 Dec 22
A consumer product composed of ≤1% of a High-Performance fragrance composition and a consumer product active is provided.
Miguel A. Teixeira, Franc T. Schiet, Judith Lynne Kerschner, Franco Doro, Timothy Young, Jill Kristine Calindas De Jesus, Yan Liang Betty Fan, Robert Allan Hunter, Volkert De Villeneuve, Caroline Celine Rose Girod, Joseph Brain, Nicole Giffin, Jason Geno, John Brahms
Filed: 7 Jun 21
Utility
Controlled Release Solid Dose Forms
22 Dec 22
The present invention is directed to a solid dose form comprising a film coating composition encapsulating a core, wherein: (i) the core comprises an active ingredient comprising at least one of a pharmaceutical, veterinary, or nutraceutical active ingredient; (ii) the film coating composition comprises ethylcellulose and guar gum, wherein the guar gum has an apparent viscosity ≥151.0 cps at a shear rate of 50 s−1 in a 1% aqueous guar gum solution measured rotationally at 20° C. after 1 minute equilibration using a 6 cm acrylic cone (1°) on a cone-plate viscometer wherein the shear is ramped up linearly from 1 to 50 s−1 in 25 steps over 29 seconds; (iii) the dose form provides controlled release of the active ingredient; (iv) the guar gum is present in an amount greater than 5 wt % based on the weight of the guar gum and ethylcellulose; and (v) the dose form is ethanol resistant.
JUERGEN SIEPMANN, YVONNE CUPPOK
Filed: 8 Apr 22
Utility
Hybrid Fragrance Encapsulate Formulation and Method for Using the Same
22 Dec 22
A hybrid encapsulate formulation obtained by mixing a starch/fragrance emulsion with a core-shell capsule suspension is provided as is a method of using the formulation in a personal care product, a beauty care product, a fabric care product, a home care product, a personal hygiene product, an oral care product and a method for releasing an encapsulated fragrance by moisture, shear, or a combination thereof.
Yabin LEI, Michael V. IMPERIALE, Lewis M. POPPLEWELL, Franklin PRINGGOSUSANTO, Ralph GENCARELLI
Filed: 23 Aug 22
Utility
Variant Maltopentaose/maltohexaose-forming Alpha-amylases
22 Dec 22
Disclosed are compositions and methods relating to maltopentaose/maltohexaose-forming α-amylases.
MANASI BHATE, HON KIT CHAN, JONATHAN LASSILA, BRIAN JAMES PAUL, SANDRA W. RAMER, PATRICIA TRAN
Filed: 20 Oct 20
Utility
Anti-CRISPR genes and proteins and methods of use
20 Dec 22
The invention relates to anti-CRISPR genes and anti-CRISPR proteins, and their uses in various biotechnology applications.
Christophe Fremaux, Philippe Horvath, Dennis A. Romero, Sylvain Moineau, Alexander Hynes, Geneviève Rousseau
Filed: 24 Apr 18
Utility
Compositions for Gut Health
15 Dec 22
Provided herein, inter alia, are compositions of short chain fatty acid (SCFA)-producing microorganisms and methods of making and using the same to inhibit pathogenic bacterial populations in the gastrointestinal tracts of an animal and additionally promote improvement of one or more metrics in an animal, such as increased bodyweight gain, decreased feed conversion ratio (FCR), improved gut barrier integrity, reduced mortality, reduced pathogen infection, and reduced pathogen shedding in feces.
John Thomas Gannon, Michael W. Bostick, Amanda Chan, Raymond E. Jackson, Victoria Vallejo Kelly, Alexander D. Kopatsis, Claus Lang, Qiong Wang, Julia Yager, Rick W. Ye
Filed: 16 Oct 20
Utility
Glucoamylase and Methods of Use Thereof
15 Dec 22
Described are a recombinant host cell, a composition comprising a glucoamylase and methods of saccharifying the starch substrate using the glucoamylase.
Zhongmei TANG, Zhenghong ZHANG, Jing GE, Lilia BABE, Xingxiang XI, Helong HAO, Chao HUANG
Filed: 13 Apr 22
Utility
Glucoamylases and methods of use, thereof
13 Dec 22
Described are methods for saccharifying starch-containing materials using a glucoamylase, methods for producing fermentation products, and fermentation products produced by the method thereof as well as methods for increasing starch digestibility in a ruminant using at least one of the glucoamylases described herein.
Jing Ge, Xiaogang Gu, Helong Hao, Karsten Matthias Kragh, Jinahua (Jalsen) Li, Wenting Li, Zhongmei Tang, Shukun Yu, Bo Zhong, Kun Zhong, Zhengzheng Zou
Filed: 6 Mar 19
Utility
Dihydroxylation of Olefins Using Osmate (Vi) Salts
8 Dec 22
A highly efficient synthesis of cis-diol compounds through cis-dihydroxylation of olefins using osmate (VI) salt as catalysts is disclosed, which has found important application in efficient large-scale preparation of, among others, α,α-cedranediol from α-cedrene.
YIGAL BECKER, MOHAMAD GARA
Filed: 4 Nov 20
Utility
Compositions and Methods for Enhanced Protein Production In Bacillus Cells
8 Dec 22
The present disclosure is generally related to compositions and methods for constructing and obtaining Bacillus sp. host cells (strains) having enhanced protein production phenotypes.
Cristina Bongiorni, Zhen Ma, Anita Van Kimmenade
Filed: 10 Nov 20
Utility
Controlling Bacterial Biofilms
8 Dec 22
Methods of controlling bacteria cells are disclosed.
Bei Yin, Thomas K. Wood
Filed: 10 Aug 22
Utility
Selection Marker Free Methods for Modifying the Genome of Bacillus and Compositions Thereof
8 Dec 22
Methods and compositions are provided for modifying the genome of Bacillus sp. cells without the use of a selectable marker and without the use of a guided Cas endonuclease.
Felipe Oseas Bendezu, Stacey Irene Robida Stubbs
Filed: 18 Nov 20
Utility
Microbial Host Cells for the Production of Heterologous Cyanuric Acid Hydrolases and Biuret Hydrolases
8 Dec 22
The present disclosure is generally related to the fields of biology, molecular biology, genetics, microbial host cells, industrial enzyme production, and the like.
Sharief Barends, Cristina Bongiorni, Feng Guo, Lori Ann Maggio-Hall, Lawrence Philip Wackett, Gregory M. Whited
Filed: 14 Oct 20
Utility
Use of High Acyl Gellan In Whipping Cream
1 Dec 22
Use of high acyl gellan in whipping cream.
FINN MADSEN, FRÉDÉRIC LIOT
Filed: 16 Feb 22
Utility
Probiotics for Use In the Prevention or Treatment of Illness And/or Symptoms Associated with Coronaviruses
24 Nov 22
This invention relates to bacterial strains, compositions comprising bacterial strains as well as methods and uses of said strains and compositions for preventing or treating illness and/or symptoms associated with a coronavirus in a subject in need thereof.
Sebastien Guery, Markus Lehtinen, Sinikka Anneli Latvala, Liisa Lehtoranta, Bryan-James Zabel, Wesley William Morovic, Charles Budinoff, Scott D. Power
Filed: 1 Apr 22
Utility
Nanosuspension formulation
22 Nov 22
A nanosuspension comprising (a) a pharmaceutical active ingredient or nutraceutical active ingredient having low solubility; (b) at least one alginate selected from the group consisting of (i) sodium alginate having a viscosity of 100 mPa·s or less in a 1% solution in water at 20° C. and (ii) potassium alginate; and (c) water.
Shirui Mao, Jian Guan, Trond Helgerud, Yeli Zhang
Filed: 18 Nov 15
Utility
Unknown
15 Nov 22
Disclosed herein is one or more subtilisin variant, nucleic acid encoding same, and compositions and methods related to the production and use thereof, including one or more Bacillus gibsonii-clade subtilisin variant that has improved stability and/or soil removal compared to one or more reference subtilisin.
Lilia Maria Babe, Richard R. Bott, David A. Estell, Harm Mulder, Frits Goedegebuur, Jian Yao, Sina Pricelius, Miles Scotcher
Filed: 17 Jun 16